Mo CA as a Screening Tool of Neuropsychological Deficits in Alcohol‐Dependent Patients

R Alarcon, B Nalpas, S Pelletier… - Alcoholism: Clinical and …, 2015 - Wiley Online Library
Background Alcoholism is known to be associated with cognitive deficits mainly concerning
visuospatial capacity, executive function, memory, and attention. These impairments may …

Clinical assessment of cognition in alcoholism.

MJ Eckardt, PR Martin - Alcoholism: clinical and experimental …, 1986 - psycnet.apa.org
Reviews standardized assessment procedures used to measure cognition, methodological
issues, findings to date, implications of findings, and directions for future research to assist …

Brief cognitive assessment in schizophrenia: normative data for the Repeatable Battery for the Assessment of Neuropsychological Status

CM Wilk, JM Gold, K Humber, F Dickerson… - Schizophrenia …, 2004 - Elsevier
Background: The Repeatable Battery for the Assessment of Neuropsychological Status
(RBANS) is a brief, standardized cognitive screening instrument that assesses several …

Neurocognitive diagnosis and cut-off scores of the Screen for Cognitive Impairment in Psychiatry (SCIP-S)

E Rojo, O Pino, G Guilera, J Gómez-Benito… - Schizophrenia …, 2010 - Elsevier
OBJECTIVES: To demonstrate the ability of the Screen for Cognitive Impairment in
Psychiatry (SCIP-S) to discriminate between cognitively-impaired individuals and those with …

Screening and diagnosis of anxiety and mood disorders in substance abuse patients

I HA Franken, V M. Hendriks - American Journal on Addictions, 2001 - Taylor & Francis
The aims of this study are (1) to study the prevalence of anxiety and mood disorders in a
clinical substance abuse population,(2) to asses the pre-and post-detoxification change in …

Diagnosis of comorbid psychiatric disorders in substance users assessed with the Psychiatric Research Interview for Substance and Mental Disorders for DSM-IV

D Hasin, S Samet, E Nunes, J Meydan… - American Journal of …, 2006 - Am Psychiatric Assoc
Objective: The authors used the Psychiatric Research Interview for Substance and Mental
Disorders for DSM-IV (PRISM-IV) to test the reliability of DSM-IV-defined disorders, including …

Psychometric evaluation of the Montreal Cognitive Assessment (MoCA) in three diverse samples

IH Bernstein, L Lacritz, CE Barlow… - The Clinical …, 2011 - Taylor & Francis
Our objective was to evaluate the utility of the Montreal Cognitive Assessment (MoCA) in
both non-clinical and clinical populations. The MoCA, a tool used widely in clinical geriatric …

Utility of the MoCA for cognitive impairment screening in long-term psychosis patients

GJ Gil-Berrozpe, AM Sánchez-Torres… - Schizophrenia …, 2020 - Elsevier
Cognitive impairment is a key feature in patients with psychotic disorders. The Montreal
Cognitive Assessment (MoCA) is a brief tool that has been shown to be effective in …

Neurocognitive dysfunction in dually-diagnosed patients: a potential roadblock to motivating behavior change

AW Blume, JM Davis, KB Schmaling - Journal of psychoactive …, 1999 - Taylor & Francis
Substance abuse has been associated with cognitive dysfunction, such as problems with
attention, reasoning, and memory. Certain psychiatric disorders also have been associated …

Evaluation of the appropriateness of multiple symptom validity indices in psychotic and non-psychotic psychiatric populations

RW Schroeder, PS Marshall - The Clinical Neuropsychologist, 2011 - Taylor & Francis
Although it is recognized that significant cognitive deficits are inherent in many psychiatric
disorders, there is minimal research on whether the deficits can cause a failing score on …